Biological studies on chimeric dimers of oxytocin and the V2-antagonist, d(CH2)5[D-Ile2, Ile4]arginine vasopressin

被引：0

作者：

Slaninová, J ^{[1
]}

Machová, A ^{[1
]}

Golser, R ^{[1
]}

Chen, L ^{[1
]}

Barany, G ^{[1
]}

机构：

[1] Acad Sci Czech Republ, Inst Organ Chem & Biochem, CR-16610 Prague, Czech Republic

来源：

PEPTIDES FOR THE NEW MILLENNIUM | 2000年

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：643 / 644

页数：2

共 50 条

[1] Chemical syntheses and biological studies on dimeric chimeras of oxytocin and the V2-antagonist, d(CH2)5[D-Ile2,Ile4]arginine vasopressin
Chen, L
Golser, R
Machová, A
Slaninová, J
Barany, G
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (24) : 5002 - 5009
[2] PREVENTION OF CEREBRAL EDEMA BY THE VASOPRESSIN ANTAGONIST D(CH2)5D-ILE2ILE4ALA9AVP IN RATS WITH EXPERIMENTAL SUBARACHNOID HEMORRHAGE
LASZLO, FA
VARGA, C
BALASPIRI, L
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 689 : 627 - 629
[3] (D-(CH2)5-DA-DF2-I4-VASOPRESSIN, A SELECTIVE VASOPRESSIN ANTAGONIST)
ROSAS, J
[J]. ARCHIVOS DE BIOLOGIA Y MEDICINA EXPERIMENTALES, 1984, 17 (02): : R175 - R175
[4] 99mTc-LABELLED VASOPRESSIN ANALOGUE d(CH2) 5[D-Tyr(Et2), Ile4, Eda9] AVP AS A POTENTIAL RADIOPHARMACEUTICAL FOR SMALL-CELL LUNG CANCER (SCLC) IMAGING
Gniazdowska, Ewa
Kozminski, Przemyslaw
Bankowski, Krzysztof
[J]. 7TH INTERNATIONAL SYMPOSIUM ON TECHNETIUM AND RHENIUM - SCIENCE AND UTILIZATION, 2011, : 343 - 346
[5] EFFECT OF THE VASOPRESSIN ANTAGONIST D(CH2)5 TYR(ET)VAVP ON DIURESIS IN RAT
LASZLO, FA
CSATI, S
BALASPIRI, L
MANNING, M
[J]. ACTA MEDICA HUNGARICA, 1984, 41 (01) : 65 - 73
[6] EFFECT OF THE AQUARETIC VASOPRESSIN ANTAGONISTS D(CH2)5[D-TYR(ET)2-VAL4]AVP AND D(CH2)5[D-PHE2-PHE4]AVP ON URINE PRODUCTION IN HEALTHY DOGS
VANOOSTERHOUT, ICAM
RIJNBERK, A
MOL, JA
[J]. HORMONE AND METABOLIC RESEARCH, 1992, 24 (05) : 244 - 245
[7] EFFECT OF THE VASOPRESSIN ANTAGONIST D/CH2/5TYR/ET/VAVP ON THE ANTIDIURETIC ACTION OF EXOGENOUS AND ENDOGENOUS VASOPRESSIN
LASZLO, FA
CSATI, S
BALASPIRI, L
[J]. ACTA ENDOCRINOLOGICA, 1984, 106 (01): : 52 - 55
[8] STUDIES ON POLYPEPTIDES .3. SYNTHESIS OF HEPTAPEPTIDES (DES-ASP1)-ARG2-ILE5-ANGIOTENSIN 2 )DES-ASP1)-D ARG2-ILE5-ANGIOTENSIN 2 )DES-ASP1)-HAR2-ILE5-ANGIOTENSIN 2 )DES-ASP1-D HAR2-ILE5-ANGIOTENSIN 2 + OCTAPEPTIDES ASP1 )NH2)-ILE5-ANGIOTENSIN 2 ASP 1 )NH2)-D ARG2-ILE5-ANGIOTENSIN 2 + GLY1-ILE5-ANGIOTENSIN 2
VISSER, GH
SCHATTENKERK, C
KERLING, KET
HAVINGA, E
[J]. RECUEIL DES TRAVAUX CHIMIQUES DES PAYS-BAS-JOURNAL OF THE ROYAL NETHERLANDS CHEMICAL SOCIETY, 1964, 83 (07): : 684 - &
[9] THE EFFECT OF THE VASOPRESSIN ANTAGONIST D(CH2)5DTYRVAVP ON THE CARDIOVASCULAR-RESPONSES TO STIMULATION OF THE PARAVENTRICULAR NUCLEUS
LAWRENCE, D
CIRIELLO, J
PITTMAN, QJ
LEDERIS, K
[J]. PROCEEDINGS OF THE WESTERN PHARMACOLOGY SOCIETY, 1984, 27 : 15 - 17
[10] ANTAGONISM OF VASOPRESSIN-INDUCED CORONARY-ARTERY CONSTRICTION BY THE VASOPRESSIN ANTAGONIST D(CH2)5TYR(ME)-AVP
KOPIA, GA
VALOCIK, RE
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (05) : 958 - 963

← 1 2 3 4 5 →